Valuation: MedCap AB

Market Cap 8.05B 813M 724M 671M 610M 1.15B 77.05B 1.16B 3.17B 40.27B 3.05B 2.99B 129B P/E 2026 *
32.4x
P/E 2027 * 27.2x
Enterprise Value 8.13B 821M 732M 678M 617M 1.16B 77.87B 1.18B 3.2B 40.7B 3.08B 3.02B 130B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 2.94x
Free-Float
88.3%
Yield 2026 *
-
Yield 2027 * -
1 day-0.33%
1 week+1.90%
Current month+2.58%
1 month+0.75%
3 months+7.80%
6 months+5.60%
Current year-2.09%
1 week 526
Extreme 526
543.5
1 month 499.2
Extreme 499.2
544.5
Current year 440
Extreme 440
582
1 year 440
Extreme 440
636
3 years 247
Extreme 247
677
5 years 135
Extreme 135
677
10 years 27
Extreme 27
677
Manager TitleAgeSince
Chief Executive Officer 50 01/11/2020
Director of Finance/CFO 52 30/04/2020
Corporate Officer/Principal 54 01/01/2020
Director TitleAgeSince
Chairman 52 01/01/2008
Director/Board Member 63 01/05/2022
Director/Board Member 66 01/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
09/02/26 Buy 1,500 0.0099%
09/02/26
Anders Larnholt Forvaltning AB
SellCompany 1,500 0.0099%
06/02/26 Sell 500 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%+1.90%-3.15%+110.78% 811M
-0.73%+3.80%-3.01%+80.74% 175B
-1.39%-2.32%+29.06%+80.01% 147B
-0.58%+0.29%+32.05%+239.58% 96.43B
+0.82%-6.16%-32.87%+14.31% 85.28B
-0.50%-1.21%-18.62%+80.56% 81.7B
+1.15%-4.49%-27.23%+57.17% 77.39B
-0.03%-0.57%-16.46%+51.87% 72.31B
-0.18%-5.56%+43.29%+148.95% 45.21B
-3.80%-3.81%+1.75%+51.92% 44.24B
Average -0.58%-1.29%+0.48%+91.59% 82.6B
Weighted average by Cap. -0.60%-0.94%+1.52%+89.76%

Financials

2026 *2027 *
Net sales 2.4B 242M 216M 200M 182M 341M 22.96B 347M 943M 12B 909M 890M 38.36B 2.69B 271M 242M 224M 204M 382M 25.72B 389M 1.06B 13.44B 1.02B 997M 42.98B
Net income 256M 25.8M 23M 21.3M 19.37M 36.34M 2.45B 36.94M 100M 1.28B 96.79M 94.76M 4.09B 317M 32.01M 28.53M 26.43M 24.03M 45.09M 3.03B 45.83M 125M 1.59B 120M 118M 5.07B
Net Debt 85M 8.58M 7.65M 7.09M 6.44M 12.09M 814M 12.29M 33.42M 425M 32.2M 31.53M 1.36B -148M -14.99M -13.37M -12.38M -11.26M -21.12M -1.42B -21.47M -58.39M -743M -56.25M -55.08M -2.38B
Projected Income Statement - Annual - MedCap AB
Logo MedCap AB
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Employees
647
Date Price Change Volume
19/10/26 SEK 537.50 +0.19% 7,864
16/10/26 SEK 536.50 +1.23% 11,986
15/10/26 SEK 530.00 -1.30% 14,355
14/10/26 SEK 537.00 +1.80% 12,932
13/10/26 SEK 527.50 0.00% 10,251
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
AAA
MarketScreener Ratings - MedCap AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
536.50SEK
Average target price
640.00SEK
Spread / Average Target
+19.29%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MedCap AB
  1. Stock Market
  2. Stocks
  3. MCAP Stock